Document is current

Article History

Received: 8 October 2021

Accepted: 23 March 2022

First Online: 7 April 2022

Declarations

:

: Imperial College Research Ethics Committee, the local research governance approved the criteria that ethical clearance was not required as there was no experimental protocols involved, there was no modification to the routine laboratory workflow or the clinical patient management and hence no informed consent was required.

: All methods were carried out in accordance with relevant guidelines and regulations.

: MP, GS declare that they have no competing interests. OMK has received speaking fees and an educational grant from Cepheid (Sunnyvale, USA) to evaluate Xpert Ultra in bronchoscopic samples. AL reports issued patents underpinning IGRA and next-generation IGRA, some of which were assigned by the University of Oxford to Oxford Immunotec, resulting in royalty entitlements for the University of Oxford and AL. AL is a named inventor on the following patents EP05729257.5, EP1735623[B1], US8,105,797[B2], EP2069792, EP2069792[B1], EP2005182, EP2005182[B1], US8,765,336[B2], EP10716313.1, EP2417456[B1], US9,377,460[B2], US9360480[B2], EP0941478[B2], EP1152012[B1], EP1735623[B1], US8105797[B2], EP1144447[B1], and US9005902[B2].